It is intriguing that LMC-based grading separated the oligodendrogliomas according to homo- but not heterozygous CDKN2A/B deletion status, except for a single grade 2 tumor not meeting any malignancy criterium besides the homozygous CDKN2A/B deletion. The gene discussed is CDKN2A; the disease is neoplasm.